Literature DB >> 26686652

A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming.

Yang Zhao1, Ting Zhao2, Jingyang Guan3, Xu Zhang3, Yao Fu3, Junqing Ye4, Jialiang Zhu3, Gaofan Meng4, Jian Ge3, Susu Yang3, Lin Cheng3, Yaqin Du3, Chaoran Zhao3, Ting Wang3, Linlin Su3, Weifeng Yang5, Hongkui Deng6.   

Abstract

Somatic cells can be reprogrammed into pluripotent stem cells (PSCs) by using pure chemicals, providing a different paradigm to study somatic reprogramming. However, the cell fate dynamics and molecular events that occur during the chemical reprogramming process remain unclear. We now show that the chemical reprogramming process requires the early formation of extra-embryonic endoderm (XEN)-like cells and a late transition from XEN-like cells to chemically-induced (Ci)PSCs, a unique route that fundamentally differs from the pathway of transcription factor-induced reprogramming. Moreover, precise manipulation of the cell fate transition in a step-wise manner through the XEN-like state allows us to identify small-molecule boosters and establish a robust chemical reprogramming system with a yield up to 1,000-fold greater than that of the previously reported protocol. These findings demonstrate that chemical reprogramming is a promising approach to manipulate cell fates.
Copyright © 2015 Elsevier Inc. All rights reserved.

Mesh:

Year:  2015        PMID: 26686652     DOI: 10.1016/j.cell.2015.11.017

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  77 in total

1.  Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds.

Authors:  Junqing Ye; Jian Ge; Xu Zhang; Lin Cheng; Zhengyuan Zhang; Shan He; Yuping Wang; Hua Lin; Weifeng Yang; Junfang Liu; Yang Zhao; Hongkui Deng
Journal:  Cell Res       Date:  2015-12-25       Impact factor: 25.617

2.  The XEN of reprogramming.

Authors:  Ergin Beyret; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2016-01-22       Impact factor: 25.617

Review 3.  Small molecules for reprogramming and transdifferentiation.

Authors:  Hua Qin; Andong Zhao; Xiaobing Fu
Journal:  Cell Mol Life Sci       Date:  2017-07-11       Impact factor: 9.261

4.  A molecular roadmap for induced multi-lineage trans-differentiation of fibroblasts by chemical combinations.

Authors:  Xiaoping Han; Hao Yu; Daosheng Huang; Yang Xu; Assieh Saadatpour; Xia Li; Lengmei Wang; Jie Yu; Luca Pinello; Shujing Lai; Mengmeng Jiang; Xueying Tian; Fen Zhang; Yanhong Cen; Yuko Fujiwara; Wei Zhu; Bin Zhou; Tianhua Zhou; Hongwei Ouyang; Jianan Wang; Guo-Cheng Yuan; Shumin Duan; Stuart H Orkin; Guoji Guo
Journal:  Cell Res       Date:  2017-01-27       Impact factor: 25.617

Review 5.  An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.

Authors:  Manash P Borgohain; Krishna Kumar Haridhasapavalan; Chandrima Dey; Poulomi Adhikari; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

6.  The All-Chemical Approach: A Solution for Converting Fibroblasts Into Myocytes.

Authors:  Yu Liu; Mark Mercola; Robert J Schwartz
Journal:  Circ Res       Date:  2016-08-05       Impact factor: 17.367

Review 7.  Chemical transdifferentiation: closer to regenerative medicine.

Authors:  Aining Xu; Lin Cheng
Journal:  Front Med       Date:  2016-05-03       Impact factor: 4.592

Review 8.  Reprogramming of germ cells into pluripotency.

Authors:  Yoichi Sekita; Toshinobu Nakamura; Tohru Kimura
Journal:  World J Stem Cells       Date:  2016-08-26       Impact factor: 5.326

Review 9.  Epigenetic Control of Reprogramming and Transdifferentiation by Histone Modifications.

Authors:  Hua Qin; Andong Zhao; Cuiping Zhang; Xiaobing Fu
Journal:  Stem Cell Rev Rep       Date:  2016-12       Impact factor: 5.739

Review 10.  Application of stem cell-derived retinal pigmented epithelium in retinal degenerative diseases: present and future.

Authors:  Mingyue Luo; Youxin Chen
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.